(Q43561343)

24 November 2017

Augmentation of antileishmanial efficacy of miltefosine in combination with tuftsin against experimental visceral leishmaniasis (English)

1 reference

24 November 2017

visceral leishmaniasis

1 reference

1 reference

Nishi Shakya

1

1 reference

24 November 2017

Shraddha A Sane

series ordinal

2

1 reference

24 November 2017

Wahajul Haq

series ordinal

3

1 reference

24 November 2017

Suman Gupta

series ordinal

4

1 reference

24 November 2017

6 March 2012

1 reference

24 November 2017

Parasitology Research

1 reference

24 November 2017

111

1 reference

24 November 2017

2

1 reference

24 November 2017

563-570

1 reference

https://scigraph.springernature.com/pub.10.1007/s00436-012-2868-z

24 November 2017

0 references

cites work

Tuftsin-bearing liposomes in treatment of macrophage-based infections.

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Tuftsin-macrophage interaction: Specific binding and augmentation of phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Developments in the treatment of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

The immune dependence of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Tuftsin: its chemistry, biology, and clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Efficacy of picroliv in combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Drug resistance in visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

In vitro and in vivo interactions between miltefosine and other antileishmanial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Leishmania-macrophage interactions: insights into the redox biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-012-2868-Z

Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide.

21 January 2018

1 reference

12 December 2020

Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles

1 reference

12 December 2020

The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro

1 reference

12 December 2020

[Tuftsin--new analogues and properties].

1 reference

12 December 2020

Specific interactions of liposomes with PMN leukocytes upon incorporating tuftsin in their bilayers

1 reference

12 December 2020

Tuftsin induced tumor necrosis activity

1 reference

12 December 2020

10.1007/S00436-012-2868-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference